Fidelity MSCI Health Care Index ETF FHLC
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.08%
- Net assets
- $3.3B
- Holdings
- 337
- 12-month distribution yield
- 1.18%
- Asset class
- Equity
Fidelity MSCI Health Care Index ETF (FHLC) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Fidelity. Its category is Equity · US (equity). Its last price was US$86.30 on 20 Oct 2026. Its expense ratio is 0.08% a year, from its prospectus dated 24 Nov 2025. It reported net assets of US$3.29 billion as of 31 Jul 2026. Its latest holdings report lists 337 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$1.02 a unit, a 12-month distribution yield of 1.18%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.08%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.08%
- Prospectus date
- Not stated
- Filed with the SEC
- 24 Nov 2025
Size and reporting
- Net assets
- $3,288,587,082
- Total assets
- $3,288,821,192
- Holdings as of
- 31 Jul 2026
- Report made public
- 23 Sep 2026 (54 days after the month end)
Top holdings
Largest 25 of 337 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 13.35% | $438.9M | Equity (common) | United States | USD |
| 2 | Johnson & Johnson | US4781601046 | 8.93% | $293.7M | Equity (common) | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 6.42% | $211.1M | Equity (common) | United States | USD |
| 4 | UnitedHealth Group Inc | US91324P1021 | 5.44% | $178.9M | Equity (common) | United States | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 4.66% | $153.1M | Equity (common) | United States | USD |
| 6 | Thermo Fisher Scientific Inc | US8835561023 | 3.09% | $101.5M | Equity (common) | United States | USD |
| 7 | Amgen Inc | US0311621009 | 3.00% | $98.8M | Equity (common) | United States | USD |
| 8 | Abbott Laboratories | US0028241000 | 2.66% | $87.6M | Equity (common) | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 2.34% | $76.9M | Equity (common) | United States | USD |
| 10 | Pfizer Inc | US7170811035 | 2.06% | $67.7M | Equity (common) | United States | USD |
| 11 | Bristol-Myers Squibb Co | US1101221083 | 1.93% | $63.4M | Equity (common) | United States | USD |
| 12 | CVS Health Corp | US1266501006 | 1.92% | $63.2M | Equity (common) | United States | USD |
| 13 | Intuitive Surgical Inc | US46120E6023 | 1.82% | $59.7M | Equity (common) | United States | USD |
| 14 | Danaher Corp | US2358511028 | 1.80% | $59.1M | Equity (common) | United States | USD |
| 15 | Vertex Pharmaceuticals Inc | US92532F1003 | 1.76% | $57.7M | Equity (common) | United States | USD |
| 16 | Stryker Corp | US8636671013 | 1.62% | $53.4M | Equity (common) | United States | USD |
| 17 | Medtronic PLC | IE00BTN1Y115 | 1.59% | $52.2M | Equity (common) | Ireland | USD |
| 18 | McKesson Corp | US58155Q1031 | 1.52% | $49.9M | Equity (common) | United States | USD |
| 19 | Elevance Health Inc | US0367521038 | 1.19% | $39.3M | Equity (common) | United States | USD |
| 20 | Regeneron Pharmaceuticals Inc | US75886F1075 | 1.15% | $37.7M | Equity (common) | United States | USD |
| 21 | Cigna Group/The | US1255231003 | 1.06% | $35.0M | Equity (common) | United States | USD |
| 22 | Boston Scientific Corp | US1011371077 | 1.00% | $33.0M | Equity (common) | United States | USD |
| 23 | HCA Healthcare Inc | US40412C1018 | 0.91% | $30.0M | Equity (common) | United States | USD |
| 24 | Cencora Inc | US03073E1055 | 0.83% | $27.4M | Equity (common) | United States | USD |
| 25 | Cardinal Health Inc | US14149Y1082 | 0.78% | $25.7M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.71% | |
| Short-term investment vehicles (cash funds) | 0.15% | |
| Equity derivatives | <0.01% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 96.50% | |
| Ireland | 2.24% | |
| United Kingdom | 0.45% | |
| Bermuda | 0.24% | |
| Canada | 0.17% | |
| Switzerland | 0.06% | |
| Netherlands | 0.05% | |
| British Virgin Islands | 0.05% | |
| Cayman Islands | 0.05% | |
| Jersey | 0.02% | |
| Israel | 0.02% | |
| Singapore | 0.01% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.87% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 83.07% | |
| Industrials | 6.90% | |
| Consumer Staples | 1.92% | |
| Technology | 0.61% | |
| Health Technology | 0.18% | |
| Consumer Discretionary | 0.12% | |
| Finance | 0.02% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $1.0180
- 12-month yield
- 1.18%
- Frequency
- Quarterly
- Latest ex-date
- 18 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($1.0180) ÷ latest price ($86.30) × 100 = 1.18%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (18 payments)
| Ex-date | Amount per unit |
|---|---|
| 18 Sep 2026 | $0.2540 |
| 18 Jun 2026 | $0.2630 |
| 20 Mar 2026 | $0.2290 |
| 19 Dec 2025 | $0.2720 |
| 19 Sep 2025 | $0.2560 |
| 20 Jun 2025 | $0.2570 |
| 21 Mar 2025 | $0.2520 |
| 20 Dec 2024 | $0.2580 |
| 20 Sep 2024 | $0.2500 |
| 21 Jun 2024 | $0.2420 |
| 15 Mar 2024 | $0.2380 |
| 15 Dec 2023 | $0.2240 |
| 15 Sep 2023 | $0.2190 |
| 16 Jun 2023 | $0.2290 |
| 17 Mar 2023 | $0.2320 |
| 16 Dec 2022 | $0.1940 |
| 16 Sep 2022 | $0.2220 |
| 18 Mar 2022 | $0.2180 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000042575) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- FHLC and VTI Vanguard Morningstar Total Stock Market ETF
- FHLC and VOO Vanguard S&P 500 ETF
- FHLC and IVV iShares Core S&P 500 ETF
- FHLC and QQQ Invesco QQQ Trust, Series 1